{"product_id":"pt-141-10mg","title":"PT-141 10mg","description":"\u003ch1 data-section-id=\"gkzk2g\" data-start=\"111\" data-end=\"125\" class=\"PDq2pG_selectionAnchorContainer\"\u003ePT-141 Facts\u003cspan aria-hidden=\"true\" class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h1\u003e\n\u003ch2 data-section-id=\"2vof5j\" data-start=\"127\" data-end=\"145\"\u003eWhat is PT-141?\u003c\/h2\u003e\n\u003cp data-start=\"147\" data-end=\"569\"\u003ePT-141, also known as \u003cstrong data-start=\"169\" data-end=\"186\"\u003eBremelanotide\u003c\/strong\u003e, is a \u003cstrong data-start=\"193\" data-end=\"226\"\u003esynthetic cyclic heptapeptide\u003c\/strong\u003e and \u003cstrong data-start=\"231\" data-end=\"264\"\u003emelanocortin receptor agonist\u003c\/strong\u003e originally developed from Melanotan II during research into melanocortin signaling. Unlike medications that work by increasing blood flow, PT-141 primarily acts within the \u003cstrong data-start=\"437\" data-end=\"463\"\u003ecentral nervous system\u003c\/strong\u003e, influencing neural pathways involved in sexual desire and arousal. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"571\" data-end=\"860\"\u003ePT-141 is one of the few peptides to receive FDA approval as a prescription drug. Under the brand name \u003cstrong data-start=\"674\" data-end=\"685\"\u003eVyleesi\u003c\/strong\u003e, it was approved in 2019 for the treatment of \u003cstrong data-start=\"732\" data-end=\"821\"\u003eacquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women\u003c\/strong\u003e. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"862\" data-end=\"865\"\u003e\n\u003ch2 data-section-id=\"15zexxv\" data-start=\"867\" data-end=\"887\"\u003eBasic Information\u003c\/h2\u003e\n\u003cul data-start=\"889\" data-end=\"1264\"\u003e\n\u003cli data-section-id=\"1x8eo7s\" data-start=\"889\" data-end=\"935\"\u003e\n\u003cstrong data-start=\"891\" data-end=\"910\"\u003eCompound Class:\u003c\/strong\u003e Synthetic cyclic peptide\u003c\/li\u003e\n\u003cli data-section-id=\"1m2p929\" data-start=\"936\" data-end=\"963\"\u003e\n\u003cstrong data-start=\"938\" data-end=\"949\"\u003eLength:\u003c\/strong\u003e 7 amino acids\u003c\/li\u003e\n\u003cli data-section-id=\"1bqc2rx\" data-start=\"964\" data-end=\"993\"\u003e\n\u003cstrong data-start=\"966\" data-end=\"990\"\u003eNaturally Occurring:\u003c\/strong\u003e No\u003c\/li\u003e\n\u003cli data-section-id=\"1n3v68a\" data-start=\"994\" data-end=\"1065\"\u003e\n\u003cstrong data-start=\"996\" data-end=\"1016\"\u003ePrimary Targets:\u003c\/strong\u003e Melanocortin receptors (primarily MC3R and MC4R)\u003c\/li\u003e\n\u003cli data-section-id=\"1xwy6q2\" data-start=\"1066\" data-end=\"1264\"\u003e\n\u003cstrong data-start=\"1068\" data-end=\"1095\"\u003ePrimary Research Areas:\u003c\/strong\u003e\n\u003cul data-start=\"1098\" data-end=\"1264\"\u003e\n\u003cli data-section-id=\"tx7vf6\" data-start=\"1098\" data-end=\"1113\"\u003eSexual desire\u003c\/li\u003e\n\u003cli data-section-id=\"16j5o95\" data-start=\"1116\" data-end=\"1132\"\u003eSexual arousal\u003c\/li\u003e\n\u003cli data-section-id=\"7gxdty\" data-start=\"1135\" data-end=\"1161\"\u003eNeuroendocrine signaling\u003c\/li\u003e\n\u003cli data-section-id=\"1hd8dbs\" data-start=\"1164\" data-end=\"1186\"\u003eMelanocortin biology\u003c\/li\u003e\n\u003cli data-section-id=\"5tkhcz\" data-start=\"1189\" data-end=\"1264\"\u003eCentral nervous system pharmacology \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"1266\" data-end=\"1269\"\u003e\n\u003ch2 data-section-id=\"uz8gfd\" data-start=\"1271\" data-end=\"1293\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp data-start=\"1295\" data-end=\"1452\"\u003ePT-141 activates melanocortin receptors within the brain, particularly \u003cstrong data-start=\"1366\" data-end=\"1374\"\u003eMC4R\u003c\/strong\u003e and \u003cstrong data-start=\"1379\" data-end=\"1387\"\u003eMC3R\u003c\/strong\u003e, which are involved in regulating sexual motivation and arousal.\u003c\/p\u003e\n\u003cp data-start=\"1454\" data-end=\"1493\"\u003eResearchers have found that PT-141 may:\u003c\/p\u003e\n\u003cul data-start=\"1495\" data-end=\"1738\"\u003e\n\u003cli data-section-id=\"mo0k1w\" data-start=\"1495\" data-end=\"1536\"\u003eActivate central melanocortin pathways.\u003c\/li\u003e\n\u003cli data-section-id=\"yjql45\" data-start=\"1537\" data-end=\"1612\"\u003eInfluence dopamine-related neural circuits involved in sexual motivation.\u003c\/li\u003e\n\u003cli data-section-id=\"1vhgc5n\" data-start=\"1613\" data-end=\"1680\"\u003eIncrease sexual desire through central nervous system mechanisms.\u003c\/li\u003e\n\u003cli data-section-id=\"1aeu5yv\" data-start=\"1681\" data-end=\"1738\"\u003eFunction independently of vascular blood-flow pathways.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1740\" data-end=\"1988\"\u003eUnlike phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil, PT-141 does \u003cstrong data-start=\"1822\" data-end=\"1829\"\u003enot\u003c\/strong\u003e primarily act by increasing genital blood flow. Instead, its effects are mediated through neural signaling in the brain. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"1990\" data-end=\"1993\"\u003e\n\u003ch2 data-section-id=\"zfwynl\" data-start=\"1995\" data-end=\"2015\"\u003eAreas of Research\u003c\/h2\u003e\n\u003ch3 data-section-id=\"1d4drzu\" data-start=\"2017\" data-end=\"2041\"\u003eFemale Sexual Desire\u003c\/h3\u003e\n\u003cp data-start=\"2043\" data-end=\"2088\"\u003ePT-141 has been extensively investigated for:\u003c\/p\u003e\n\u003cul data-start=\"2090\" data-end=\"2194\"\u003e\n\u003cli data-section-id=\"8rjfui\" data-start=\"2090\" data-end=\"2132\"\u003eHypoactive sexual desire disorder (HSDD)\u003c\/li\u003e\n\u003cli data-section-id=\"auu08a\" data-start=\"2133\" data-end=\"2152\"\u003eSexual motivation\u003c\/li\u003e\n\u003cli data-section-id=\"16j5o95\" data-start=\"2153\" data-end=\"2169\"\u003eSexual arousal\u003c\/li\u003e\n\u003cli data-section-id=\"17714d6\" data-start=\"2170\" data-end=\"2194\"\u003eFemale sexual function\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2196\" data-end=\"2330\"\u003eLarge Phase III clinical trials contributed to its FDA approval for HSDD in premenopausal women. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"2332\" data-end=\"2335\"\u003e\n\u003ch3 data-section-id=\"1wfijav\" data-start=\"2337\" data-end=\"2361\"\u003eMale Sexual Function\u003c\/h3\u003e\n\u003cp data-start=\"2363\" data-end=\"2443\"\u003eResearchers have also studied PT-141 in men, including investigations involving:\u003c\/p\u003e\n\u003cul data-start=\"2445\" data-end=\"2540\"\u003e\n\u003cli data-section-id=\"q097k1\" data-start=\"2445\" data-end=\"2467\"\u003eErectile dysfunction\u003c\/li\u003e\n\u003cli data-section-id=\"16j5o95\" data-start=\"2468\" data-end=\"2484\"\u003eSexual arousal\u003c\/li\u003e\n\u003cli data-section-id=\"1iakpyy\" data-start=\"2485\" data-end=\"2540\"\u003eMen who did not adequately respond to PDE5 inhibitors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2542\" data-end=\"2692\"\u003eAlthough encouraging findings have been reported in some studies, PT-141 is \u003cstrong data-start=\"2618\" data-end=\"2653\"\u003enot FDA-approved for use in men\u003c\/strong\u003e. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"2694\" data-end=\"2697\"\u003e\n\u003ch3 data-section-id=\"14dr3sf\" data-start=\"2699\" data-end=\"2726\"\u003eNeuroendocrine Research\u003c\/h3\u003e\n\u003cp data-start=\"2728\" data-end=\"2830\"\u003eBecause PT-141 targets melanocortin receptors in the brain, researchers have investigated its role in:\u003c\/p\u003e\n\u003cul data-start=\"2832\" data-end=\"3005\"\u003e\n\u003cli data-section-id=\"wfylfa\" data-start=\"2832\" data-end=\"2866\"\u003eCentral nervous system signaling\u003c\/li\u003e\n\u003cli data-section-id=\"196q303\" data-start=\"2867\" data-end=\"2890\"\u003eDopaminergic pathways\u003c\/li\u003e\n\u003cli data-section-id=\"1oxcjif\" data-start=\"2891\" data-end=\"2909\"\u003eReward circuitry\u003c\/li\u003e\n\u003cli data-section-id=\"14cg4u6\" data-start=\"2910\" data-end=\"2935\"\u003eBehavioral neuroscience\u003c\/li\u003e\n\u003cli data-section-id=\"1gxprl9\" data-start=\"2936\" data-end=\"3005\"\u003eMelanocortin receptor biology\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong data-start=\"4789\" data-end=\"4811\"\u003eResearch Use Only:\u003c\/strong\u003e This product is intended exclusively for laboratory and scientific research by qualified professionals. It is \u003cstrong data-start=\"4922\" data-end=\"4966\"\u003enot intended for human or veterinary use\u003c\/strong\u003e, diagnosis, treatment, cure, or prevention of any disease. This product has \u003cstrong data-start=\"5043\" data-end=\"5124\"\u003enot been evaluated or approved by the U.S. Food and Drug Administration (FDA)\u003c\/strong\u003e for research formulations. Handle and store in accordance with applicable laboratory safety procedures.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42991951020103,"sku":null,"price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/9104\/9031\/files\/PT-14110mg.png?v=1784748511","url":"https:\/\/dnyay.us\/products\/pt-141-10mg","provider":"DNYAY","version":"1.0","type":"link"}